Voyager Therapeutics, Inc. · NASDAQ:VYGR
Sandrock Alfred sold 11,511 Voyager Therapeutics, Inc. shares (Form 4)
Traded Apr 2, 2026 · Filed Apr 3, 2026
On Apr 2, 2026, Sandrock Alfred (Director, President and CEO) sold 11,511 Voyager Therapeutics, Inc. shares at US$3.87 for US$44,548 under a trading plan, leaving 472,549 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 11,511 shares
- Price
- US$3.87
- Value
- US$44,548
- Holding after
- 472,549 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common Stock | Sale | 11,511 | US$3.87 | 472,549 | Direct |
Source
Related
- Voyager Therapeutics, Inc.
- Sandrock Alfred
- Voyager Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 31, 2026
- Schedule 13G/A · EcoR1 Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Form 4 · Shiferman Gregory L. · Apr 3, 2026